Lonza signs manufacturing deal with Athera

Lonza signs manufacturing deal with Athera

4:31 PM, 29th March 2011
Lonza signs manufacturing deal with Athera
Stephan Kutzer, Head-Custom Manufacturing Division, Lonza.


BASEL, SWITZERLAND: Lonza recently said that it has signed a new development and manufacturing agreement with Athera Biotechnologies AB, part of the Karolinska Development AB portfolio. Lonza will initiate cell line and process development for Athera’s monoclonal antibody PC-mAb. Athera’s PC-mAb is intended for the treatment of patients with Acute Coronary Syndrome who are at an increased risk of secondary cardiovascular events and death.


This agreement secures a development and cGMP manufacturing plan for Athera. Lonza will initiate cell line and process development, using Lonza’s GS Gene Expression SystemTM.


“Lonza is pleased to continue our support of emerging biotech companies with this commitment to Athera’s promising pipeline. The PC-mAb project from Athera fits well with Lonza’s core competencies and technical experience,” said Stephan Kutzer, Head-Custom Manufacturing Division, Lonza.

© WOC News




Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

CP Chem study to develop ethane cracker on US Gulf Coast

  THE WOODLANDS, US: Chevron Phillips Chemical Company LP (Chevron Phillips Chemical) said that it is advancing a feasibility study to construct ...

Read more
Shin-Etsu operations in Japan remain suspended

  TOKYO, JAPAN: Shin-Etsu Group’s reported that there has been little change in their situation since March 22nd. All of operations at bot ...

Read more
Lonza to invest £16 million in UK facility

  BASEL, SWITZERLAND: Lonza will invest £16 million to further develop the flexibility and capability of its Slough, UK biopharmaceutical ...

Read more
Sumitomo and Samsung form joint venture for LED business

  By co-operating to generate synergies in technological development, marketing and R&D, both companies seek to expand their businesses in t ...

Read more
Perstorp extends 2- Ethylhexanoic Acid capacity in Singapore

  PERSTORP, SWEDEN: Perstorp is extending capacity for 2-EHA in Europe and Asia by establishing production at the group’s manufacturing un ...

Read more
3i to sell Azelis chemicals firm: sources

  LONDON, UK: British private equity firm 3i Group has kicked off the sale of Azelis, a Belgium headquartered chemicals distributor with 1 billi ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X